Johns Hopkins Uganda HIV Prevention and Treatment Trials
The Johns Hopkins University - Uganda Clinical Trials Unit
Tests new HIV vaccines, prevention approaches, and treatments for adults, pregnant women, and children served by clinics in Uganda.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11458377 on NIH RePORTER |
What this research studies
You would join local clinic sites in Kampala or Rakai where researchers run trials of vaccines, prevention strategies, and new HIV therapies. The unit has long-running sites focused on preventing mother-to-child transmission, pediatric HIV care, and prevention for high-risk women, and is adding adult treatment and vaccine programs to reach more people. Trials are run in partnership with international DAIDS clinical networks and build on decades of experience in Uganda. Participation typically involves medical exams, blood tests, follow-up visits, and sometimes taking study medications or vaccines.
Who could benefit from this research
Good fit: People living with HIV, pregnant or breastfeeding women, high-risk HIV-negative women, and eligible children connected to participating clinics in Kampala or Rakai are the ideal candidates.
Not a fit: People who live outside the study areas, do not meet the age or risk criteria, or have medical conditions that make them ineligible are unlikely to benefit directly from this effort.
Why it matters
Potential benefit: Could lead to safer, more effective HIV vaccines, prevention methods, and treatments that reduce infections and improve care for people in Uganda and beyond.
How similar studies have performed: Previous Johns Hopkins and DAIDS-supported trials have produced important advances in PMTCT and HIV treatment, while vaccine work remains promising but challenging.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Fowler, Mary Glenn — Johns Hopkins University
- Study coordinator: Fowler, Mary Glenn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.